AI

biotech

Revvity to acquire Human Cell Design

Jim Cornall - September 16, 2026

biotech

Engineered immune cells trial to fight colorectal cancer approved

Jim Cornall - September 16, 2026

biotech

Elix and Axcelead DDP to collaborate on targeted protein degrader discovery

Jim Cornall - September 16, 2026

biotech

Lotus Neuro launches to deliver therapies across blood-brain barrier

Jim Cornall - September 15, 2026

AI

11 start-ups selected for Irish AI accelerator programme

admin - May 13, 2024

AI

Researcher in Norway increases 6G network capacity

Jim Cornall - May 6, 2024

AI

Boost for security in artificial intelligence and image processing

Jim Cornall - April 29, 2024

AI

AI tool can measure work-related stress

Jim Cornall - March 28, 2024

AI

AI infrastructure survey reveals GPU challenges

Jim Cornall - March 15, 2024

AI

Ten ways AI will shape the next five years

Jim Cornall - January 17, 2024

AI

Oman uses AI to relay real-time election results to citizens

Jim Cornall - November 13, 2023

AI

Can AI change aviation with guaranteed safe landings?

Jim Cornall - October 18, 2023

1...567 Page 6 of 7

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Revvity to acquire Human Cell Design

Jim Cornall - September 16, 2026 0

Revvity, Inc. has entered into a definitive agreement to acquire Human Cell Design (HCD), a France-based biotechnology company specialising in human cell models and...

Engineered immune cells trial to fight colorectal cancer approved

biotech Jim Cornall - September 16, 2026 0

Elix and Axcelead DDP to collaborate on targeted protein degrader discovery

biotech Jim Cornall - September 16, 2026 0

Lotus Neuro launches to deliver therapies across blood-brain barrier

biotech Jim Cornall - September 15, 2026 0

Antibody targeting TSLP achieves positive results in asthma study

biotech Jim Cornall - September 15, 2026 0